Article
Regeneron Awarded $407 Million In Amgen Antitrust Suit
On May 15, 2025, a jury returned a verdict finding Amgen Inc. ("Amgen") liable for antitrust violations and awarding Regeneron Pharmaceuticals, Inc. ("Regeneron") over $400 million in damages.
Goodwin Procter LLP